Hitoshi Suzuki Selected Research

Hitoshi Suzuki Research Topics

Disease

67	IGA Glomerulonephritis (IGA Nephropathy) 06/2022 - 01/2004
31	Proteinuria 06/2022 - 05/2005
27	Heart Failure 07/2018 - 01/2002
19	Infections 02/2021 - 05/2002
18	Hematuria 05/2022 - 01/2004
18	Glomerulonephritis 02/2021 - 11/2003
18	Nephritis 02/2021 - 01/2002
11	Inflammation (Inflammations) 05/2020 - 11/2003
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2014
7	Chronic Renal Insufficiency 10/2018 - 11/2011
7	Hypertension (High Blood Pressure) 11/2017 - 01/2014
6	Disease Progression 04/2022 - 09/2012
6	Neoplasms (Cancer) 01/2021 - 04/2003
6	Diabetes Mellitus 01/2021 - 10/2015
6	Purpura 11/2019 - 08/2004
6	Death (Near-Death Experience) 01/2018 - 01/2012
5	Obesity 06/2020 - 01/2014
5	Vasculitis (Vasculitides) 11/2019 - 03/2007
5	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2007 - 12/2002
4	Kidney Diseases (Kidney Disease) 02/2021 - 07/2010
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 05/2015
4	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2014
4	IgA Vasculitis (Purpura, Schoenlein Henoch) 12/2019 - 01/2007
4	Lupus Nephritis 01/2019 - 02/2008
4	Liver Diseases (Liver Disease) 01/2018 - 01/2014
4	Ventricular Tachycardia 01/2018 - 02/2008
4	Fever (Fevers) 07/2015 - 05/2002
4	Apnea 05/2015 - 09/2012
4	Brain Diseases (Brain Disorder) 04/2009 - 05/2005
4	Respiratory Syncytial Virus Infections 11/2008 - 05/2002
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 06/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2005
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 03/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2020 - 08/2011
3	Body Weight (Weight, Body) 06/2020 - 12/2004
3	Arthritis (Polyarthritis) 01/2020 - 05/2011
3	Anemia 10/2018 - 01/2014
3	Cicatrix (Scar) 03/2018 - 01/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2016 - 11/2012
3	Atrial Fibrillation 11/2016 - 04/2015
3	Hyperuricemia 10/2015 - 01/2014
3	Hyperlipidemias (Hyperlipidemia) 01/2015 - 06/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 03/2008
3	Rupture 03/2014 - 06/2003

Drug/Important Bio-Agent (IBA)

55	Immunoglobulin A (IgA)IBA 06/2022 - 01/2004
28	galactosyl-deficient IgA1IBA 06/2022 - 01/2007
23	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 03/2006
18	Galactose (Galactopyranose)FDA LinkGeneric 01/2022 - 01/2007
16	Polysaccharides (Glycans)IBA 01/2018 - 01/2007
14	Immunoglobulin G (IgG)IBA 01/2022 - 07/2004
11	AutoantibodiesIBA 01/2021 - 02/2011
10	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2013
10	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2003
10	SteroidsIBA 11/2020 - 12/2002
8	Prednisolone (Predate)FDA LinkGeneric 02/2021 - 01/2004
8	CytokinesIBA 05/2020 - 05/2002
8	mizoribineIBA 08/2007 - 01/2004
7	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 04/2007
7	Methylprednisolone FDA LinkGeneric 02/2021 - 04/2003
6	AutoantigensIBA 05/2020 - 09/2012
6	AntibodiesIBA 01/2019 - 09/2003
6	C-Reactive ProteinIBA 01/2018 - 05/2002
5	Messenger RNA (mRNA)IBA 04/2022 - 05/2007
5	LigandsIBA 01/2021 - 01/2015
5	Complement System Proteins (Complement)IBA 01/2020 - 11/2003
5	Troponin T (Troponin T1)IBA 05/2015 - 01/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 05/2002
5	Pharmaceutical PreparationsIBA 12/2013 - 10/2006
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2008 - 01/2005
4	oxidized low density lipoproteinIBA 01/2021 - 06/2007
4	InterleukinsIBA 05/2020 - 10/2005
4	Uric Acid (Urate)IBA 01/2018 - 01/2012
4	Interleukin-6 (Interleukin 6)IBA 11/2017 - 05/2002
4	EnzymesIBA 05/2016 - 04/2004
4	Peptides (Polypeptides)IBA 01/2016 - 05/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2003
3	LDL CholesterolIBA 01/2021 - 06/2018
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020 - 03/2007
3	AntigensIBA 01/2020 - 04/2004
3	AcetoneIBA 07/2018 - 10/2017
3	CreatinineIBA 06/2018 - 03/2005
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 07/2013
3	Hemoglobins (Hemoglobin)IBA 10/2017 - 04/2015
3	Toll-Like Receptor 9IBA 04/2017 - 12/2008
3	DiureticsIBA 10/2015 - 12/2013
3	AlbuminsIBA 03/2015 - 09/2003
3	human NPPA protein (carperitide)IBA 01/2015 - 12/2013
3	Tolvaptan FDA Link 01/2015 - 12/2013
3	VaccinesIBA 01/2012 - 01/2009
3	Ceruloplasmin (Ferroxidase)IBA 12/2007 - 01/2006
3	Familial apoceruloplasmin deficiencyIBA 12/2007 - 01/2006

Therapy/Procedure

40	Therapeutics 01/2021 - 04/2003
8	Drug Therapy (Chemotherapy) 04/2022 - 08/2004
7	Tonsillectomy 12/2017 - 11/2006
7	Cardiac Resynchronization Therapy 08/2017 - 01/2012
6	Patient Readmission 01/2018 - 01/2014
3	Ligation 09/2021 - 05/2019
3	Blood Component Removal (Apheresis) 01/2021 - 06/2007
3	Plasmapheresis 11/2020 - 08/2004
3	Defibrillators (Defibrillator) 06/2016 - 02/2008